Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Completed Phase 2 Trials for Arsenic trioxide (DB01169)

Also known as: Transitional cell cancer of the renal pelvis and ureter recurrent / Renal pelvis and ureter transitional cell cancer recurrent / Renal pelvis and ureteric cancer recurrent transitional cell / Renal pelvis and ureteral cancer transitional cell recurrent / Renal pelvis and ureteric cancer transitional cell recurrent

IndicationStatusPhase
DBCOND0028816 (Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00009867Arsenic Trioxide in Treating Patients With Urothelial CancerTreatment